NOVAVAX INC reports $294 million Q1 loss
The company generated $81 million in quarterly revenue
By USInMinutes
Published - May 09, 2023, 09:59 AM ET
Last Updated - Jul 18, 2023, 03:33 PM EDT
NOVAVAX INC [NVAX] has reported fiscal Q1 loss of $294 million.
On a per-share basis, the DE based company said its diluted earnings are $3.41.
The Biological Products, Except Diagnostic Substances firm posted revenue of $81 million in this period.
